Coordinated guidelines advance personalized phage therapy for antibiotic-resistant infections
Antibiotic-resistant infections are prompting researchers to explore bacteriophages, viruses that can specifically target and kill harmful bacteria. Rather than relying on a broad antibiotic, personalized phage therapy matches patients with viruses selected for activity against their particular bacterial infections.
An international team has now released the first coordinated guidelines for this approach, providing a roadmap for clinical implementation. The guidance is intended to help standardize safety, treatment selection, and delivery as the field remains experimental.
Early findings are encouraging. One study reported that 77% of patients improved, while targeted bacteria disappeared in 61% of cases. These results support further clinical evaluation, although the coordinated guidelines still reflect an emerging treatment approach rather than established standard care.